Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Assets (2019 - 2025)

Historic Assets for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to $106.7 million.

  • aTYR PHARMA's Assets rose 1641.2% to $106.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.7 million, marking a year-over-year increase of 1641.2%. This contributed to the annual value of $96.8 million for FY2024, which is 1974.51% down from last year.
  • As of Q3 2025, aTYR PHARMA's Assets stood at $106.7 million, which was up 1641.2% from $101.5 million recorded in Q2 2025.
  • In the past 5 years, aTYR PHARMA's Assets ranged from a high of $136.8 million in Q1 2023 and a low of $49.0 million during Q2 2021
  • Its 5-year average for Assets is $103.4 million, with a median of $104.8 million in 2022.
  • In the last 5 years, aTYR PHARMA's Assets skyrocketed by 19834.48% in 2021 and then crashed by 2674.76% in 2024.
  • Quarter analysis of 5 years shows aTYR PHARMA's Assets stood at $115.5 million in 2021, then dropped by 17.09% to $95.8 million in 2022, then rose by 25.96% to $120.7 million in 2023, then fell by 19.75% to $96.8 million in 2024, then rose by 10.14% to $106.7 million in 2025.
  • Its Assets was $106.7 million in Q3 2025, compared to $101.5 million in Q2 2025 and $97.2 million in Q1 2025.